 |




|
 |
 |

you are here > home
> tools > taqman
> introduction
The real-time TaqMan PCR and applications in veterinary
medicine
Christian M. Leutenegger
Introduction
The polymerase chain reaction (PCR), first described in 1985, is a highly
sensitive and specific technique used for the detection of nucleic acids
[55]. The inventor of this technology
earned a Nobel prize for his achievement [43,44],
which has revolutionised research and diagnostic possibilities. Qualitative
PCR is a well established and straightforward technology, but quantification
of specific nucleic acids present in a sample is a demanding task. Accurate
quantification is hampered by a number of variations that may occur
during sample preparation, storage or the course of the reaction. Even
minor variations in reaction conditions are greatly magnified by the
exponential nature of the PCR amplification. These variations may partly
be overcome by normalising the amount of PCR products of the specific
template with respect to an internal reference template. Considering
the hundreds of papers published on the use of quantitative PCR, it
is not surprising that a great variety of protocols exist. These methods
are almost exclusively restricted to use in research because of two
factors they have in common: they are difficult to perform and are costly
to run.
In the need for faster, more accurate and more economic systems with
a high throughput capacity, three keywords have become important for
the development of the next-generation of PCR systems: automation, standardisation
and miniaturisation. The development process was accelerated by combining
computer-assisted PCR with laser technology so that now the laser-guided
detection of PCR products, with the help of a so-called TaqMan probe,
and the real-time accumulation of fluorescent data points for every
PCR cycle virtually replace the need for a time-consuming post-amplification
step. In addition, using an internationally standardised 96-well microtitre
plate format enables large numbers of samples to be screened within
a few hours. The TaqMan principle is implemented in an Applied Biosystems
(ABI) Prism Sequence Detection device (Applied
Biosystems, Foster City, California, USA), which is one of the most
sophisticated technologies currently available and offers a unique platform
for further development.
Read more...

home
| editorial | news
| reviews | education
| tools | policies
| archives | about
vst
|
 |
 |